Testing effectiveness (Phase 2)Study completedNCT02919306
What this trial is testing
Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults
Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 27